Companies: 10,795·Total market cap: $144.5T
Hinge Health, Inc.

Hinge Health, Inc.

HNGENYSEHealthcare● Active
$63.76
+$0.14(+0.21%)
Market Cap$4.9B
P/E Ratio
52W High$65.7189
52W Low$30.08
Overview

Hinge Health, Inc. (HNGE) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

hnge · stock forecast · 13 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 13 Wall Street analysts in the past 3 months

SellBuy

Buy

13 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
13
Hold
0
Sell
0
Strong Sell
0
Total: 13 · Buy rate: 100.0%

12-Month Price Target

High

$95.00

Consensus

$65.82

+3.2% upside

Low

$45.00

Median: $63 · Last Close: $63.77

The Hinge Health, Inc. (HNGE) analyst consensus is Buy, based on ratings from 13 Wall Street analysts over the past 3 months. The average 12-month HNGE price target is $65.82, representing +3.2% upside from the current price of $63.77.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $66 (3.2%)

Consensus Target

$65.82

3.2% upside

High Target

$95

49.0%

Low Target

$45

-29.4%

Current Price

$63.77

as of today

Based on analyst price targets, the HNGE stock price prediction for the next 12 months ranges from $45 to $95. The consensus HNGE price forecast of $65.82 implies 3.2% upside from the current price of $63.77.

Short-Term Price Prediction

Bull

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$66.955.00%

1-day model range: $66.52–$67.39. Peak: $67.39 (+5.00%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$112+76.0%
2028$163+156.4%
2029$208+226.5%
2030$242+280.2%
2031+317.6%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

93%0%7%
13Buy
0Neutral
1Sell
RSI (14)73.9Overbought
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · HNGE · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$61.50BUY
MA 10$58.61BUY
MA 20$56.67BUY
MA 50$48.45BUY
MA 100$44.63BUY
MA 200$47.47BUY
Current $HNGE · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$61.87BUY
EMA 10$59.74BUY
EMA 20$56.81BUY
EMA 50$51.38BUY
EMA 100$48.16BUY
EMA 200$47.71BUY
Current $HNGE · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Canaccord Genuity2026-06-04
Maintains
BuyBuy
Stifel2026-05-06
Maintains
BuyBuy
Citizens2026-05-06
Maintains
Market OutperformMarket Outperform
Canaccord Genuity2026-05-06
Maintains
BuyBuy
RBC Capital2026-05-06
Maintains
OutperformOutperform
Wells Fargo2026-05-06
Maintains
OverweightOverweight
Needham2026-05-06
Maintains
BuyBuy
Barclays2026-05-06
Maintains
OverweightOverweight
Evercore ISI Group2026-04-08
Maintains
OutperformOutperform
RBC Capital2026-03-11
Maintains
OutperformOutperform

Wall Street analysts have recently issued updated ratings on Hinge Health, Inc. (HNGE) stock. Of the recent 36 rating actions, 0 were upgrades and 0 were downgrades. 13 analysts currently cover HNGE.

Analyst Recommendation Trends

Buy ratings413
Hold ratings00
Sell ratings00

HNGE analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 4 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$802M

↓ 30.0% YoY

Revenue Next Year

$966M

↑ 20.5% YoY

EPS This Year

$2.50

EPS Next Year

$3.12

↑ 24.7% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast HNGE EPS of $2.50 for the current fiscal year, based on estimates from 9 analysts. The HNGE revenue forecast is $802M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The HNGE stock forecast is supported by two independent data sources: analyst consensus ratings from 13 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus HNGE price target is $65.82 (+3.2% upside), with an analyst consensus of Buy.

The HNGE short-term stock prediction for tomorrow is $66.95 (+5.00%). The HNGE stock price prediction for 2027 estimates an average of $112. The HNGE stock prediction for 2030 projects a range of $225–$260.

Hinge Health, Inc. trades on NYSE under the ticker HNGE. The HNGE stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

HNGE forecast · 8 questions

According to 13 Wall Street analysts, the average 12-month HNGE price target is $65.82, with a high forecast of $95.00 and a low of $45.00. The median price target is shown in the chart above when available. This implies +3.2% potential upside from the current price of $63.77.

HNGE price targetWhat is HNGE price targetHNGE analyst price targetHNGE 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.